Anaplastic Large Cell Lymphoma
Oncology·MeSH: Enteropathy-Associated T-Cell Lymphoma
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
1 drug in development·1 company·4 clinical trials
Drug Pipeline by Phase
Phase 2(1)
Frequently asked questions
How many drugs are in development for Anaplastic Large Cell Lymphoma?
BioSniper tracks 1 drug in development for Anaplastic Large Cell Lymphoma across 1 company.
How many clinical trials target Anaplastic Large Cell Lymphoma?
There are 4 clinical trials targeting Anaplastic Large Cell Lymphoma tracked by BioSniper.
What is the prevalence of Anaplastic Large Cell Lymphoma?
The estimated prevalence of Anaplastic Large Cell Lymphoma is approximately 56.0 per 100,000 population.
Deep-dive into Anaplastic Large Cell Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis